Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCDNA3/GFP-PR Citations (3)

Originally described in: Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.
Lindsten K, Uhlikova T, Konvalinka J, Masucci MG, Dantuma NP Antimicrob Agents Chemother. 2001 Sep . 45(9):2616-22.
PubMed Journal

Articles Citing pCDNA3/GFP-PR

Articles
New heteroaryl carbamates: Synthesis and biological screening in vitro and in mammalian cells of wild-type and mutant HIV-protease inhibitors. Tramutola F, Armentano MF, Berti F, Chiummiento L, Lupattelli P, D'Orsi R, Miglionico R, Milella L, Bisaccia F, Funicello M. Bioorg Med Chem. 2019 May 1;27(9):1863-1870. doi: 10.1016/j.bmc.2019.03.041. Epub 2019 Mar 21. PubMed
Vimentin filaments interact with the actin cortex in mitosis allowing normal cell division. Duarte S, Viedma-Poyatos A, Navarro-Carrasco E, Martinez AE, Pajares MA, Perez-Sala D. Nat Commun. 2019 Sep 13;10(1):4200. doi: 10.1038/s41467-019-12029-4. PubMed
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cellsurface proteins on target cells. Aoyama S, Yasuda S, Li H, Watanabe D, Umezawa Y, Okada K, Nogami A, Miura O, Kawamata N. Int J Mol Med. 2022 Apr;49(4). pii: 42. doi: 10.3892/ijmm.2022.5097. Epub 2022 Feb 4. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.